ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 145 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,099 | -50.6% | 207,077 | -11.3% | 0.00% | 0.0% |
| Q2 2023 | $2,224 | -84.8% | 233,418 | -82.5% | 0.00% | -85.7% |
| Q1 2023 | $14,631 | -16.3% | 1,330,065 | +12.7% | 0.01% | -12.5% |
| Q4 2022 | $17,470 | -99.4% | 1,180,384 | +738.1% | 0.01% | +166.7% |
| Q3 2022 | $2,691,000 | +262.7% | 140,837 | +304.3% | 0.00% | – |
| Q2 2022 | $742,000 | +1.6% | 34,836 | -8.2% | 0.00% | -100.0% |
| Q1 2022 | $730,000 | – | 37,938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $165,956,000 | 12.78% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $57,330,000 | 6.84% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $10,874,000 | 3.97% |
| Logos Global Management LP | 1,525,000 | $29,143,000 | 3.58% |
| 1492 Capital Management LLC | 178,320 | $3,408,000 | 2.45% |
| Cormorant Asset Management, LP | 1,000,000 | $19,110,000 | 1.34% |
| MPM BioImpact LLC | 257,185 | $4,915,000 | 1.16% |
| Orbimed Advisors | 2,800,000 | $53,508,000 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 220,985 | $4,223,000 | 0.83% |
| Rubric Capital Management LP | 472,047 | $9,021,000 | 0.45% |